| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 7.87e-05 | 10 | 27 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 1.36e-04 | 13 | 27 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 1.36e-04 | 13 | 27 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | cAMP binding | 5.18e-04 | 25 | 27 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.61e-04 | 26 | 27 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 9.06e-04 | 33 | 27 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.27e-03 | 39 | 27 | 2 | GO:0030551 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.24e-03 | 52 | 27 | 2 | GO:0005272 | |
| GeneOntologyCellularComponent | HCN channel complex | 1.11e-05 | 4 | 29 | 2 | GO:0098855 | |
| Domain | TMEM191C | 2.33e-06 | 2 | 29 | 2 | PF15194 | |
| Domain | TMEM191B/C | 2.33e-06 | 2 | 29 | 2 | IPR028186 | |
| Domain | Ion_trans_N | 1.39e-05 | 4 | 29 | 2 | PF08412 | |
| Domain | Ion_trans_N | 1.39e-05 | 4 | 29 | 2 | IPR013621 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 2.09e-04 | 14 | 29 | 2 | IPR003938 | |
| Domain | cNMP-bd_CS | 2.76e-04 | 16 | 29 | 2 | IPR018488 | |
| Domain | CNMP_BINDING_1 | 1.12e-03 | 32 | 29 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.12e-03 | 32 | 29 | 2 | PS00889 | |
| Domain | cNMP | 1.27e-03 | 34 | 29 | 2 | SM00100 | |
| Domain | cNMP_binding | 1.27e-03 | 34 | 29 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 1.34e-03 | 35 | 29 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.34e-03 | 35 | 29 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 1.58e-03 | 38 | 29 | 2 | IPR018490 | |
| Domain | - | 2.51e-03 | 48 | 29 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 2.83e-03 | 51 | 29 | 2 | IPR014710 | |
| Domain | HEAT | 3.65e-03 | 58 | 29 | 2 | IPR000357 | |
| Domain | HEAT_REPEAT | 5.27e-03 | 70 | 29 | 2 | PS50077 | |
| Domain | Ion_trans_dom | 1.35e-02 | 114 | 29 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.35e-02 | 114 | 29 | 2 | PF00520 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 26168232 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 19135060 | ||
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 6.71e-07 | 2 | 29 | 2 | 17548059 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 21456027 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 6.71e-07 | 2 | 29 | 2 | 11675786 | |
| Pubmed | TERT promoter mutations associate with MC1R variants in melanoma patients. | 6.71e-07 | 2 | 29 | 2 | 27930874 | |
| Pubmed | EP3 activation facilitates bladder excitability via HCN channels on ICCs. | 2.01e-06 | 3 | 29 | 2 | 28131828 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 33181864 | ||
| Pubmed | Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. | 2.01e-06 | 3 | 29 | 2 | 22652004 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 21187420 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 21945247 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 18936156 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 22006928 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 16043489 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 22748890 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 33444485 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 4.02e-06 | 4 | 29 | 2 | 9630217 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 9405696 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 12928435 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 21615589 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 20140458 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 34429357 | ||
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 6.70e-06 | 5 | 29 | 2 | 15564593 | |
| Pubmed | Galanin receptor 3 - A new pharmacological target in retina degeneration. | 6.70e-06 | 5 | 29 | 2 | 36693600 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 25761792 | ||
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 1.41e-05 | 7 | 29 | 2 | 19421833 | |
| Pubmed | Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication. | 1.41e-05 | 7 | 29 | 2 | 21829167 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 16382102 | ||
| Pubmed | Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. | 4.41e-05 | 12 | 29 | 2 | 17482496 | |
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 6.07e-05 | 14 | 29 | 2 | 29107716 | |
| Pubmed | Genome-wide association study identifies three new melanoma susceptibility loci. | 6.07e-05 | 14 | 29 | 2 | 21983787 | |
| Pubmed | HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes. | 7.00e-05 | 15 | 29 | 2 | 22530760 | |
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 21147989 | ||
| Pubmed | 1.02e-04 | 18 | 29 | 2 | 27180262 | ||
| Pubmed | 1.40e-04 | 21 | 29 | 2 | 30270038 | ||
| Pubmed | Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. | 3.08e-04 | 31 | 29 | 2 | 17473172 | |
| Pubmed | 3.49e-04 | 33 | 29 | 2 | 17955473 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 5.61e-04 | 462 | 29 | 4 | 31138677 | |
| Pubmed | 6.79e-04 | 46 | 29 | 2 | 37207277 | ||
| Pubmed | 7.15e-04 | 493 | 29 | 4 | 15368895 | ||
| Interaction | PTPA interactions | 1.37e-05 | 115 | 26 | 4 | int:PTPA | |
| Interaction | HCN4 interactions | 5.73e-05 | 9 | 26 | 2 | int:HCN4 | |
| Interaction | CDKN2A interactions | 6.08e-05 | 335 | 26 | 5 | int:CDKN2A | |
| Interaction | HCN3 interactions | 8.74e-05 | 11 | 26 | 2 | int:HCN3 | |
| Cytoband | Xq26.2 | 1.44e-04 | 28 | 29 | 2 | Xq26.2 | |
| Cytoband | 22q11.21 | 2.25e-03 | 111 | 29 | 2 | 22q11.21 | |
| GeneFamily | Cyclic nucleotide gated channels | 2.88e-05 | 10 | 15 | 2 | 250 | |
| Coexpression | FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN | 6.34e-05 | 70 | 29 | 3 | M5370 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP | 6.34e-05 | 197 | 29 | 4 | M4980 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP | 6.47e-05 | 198 | 29 | 4 | M5007 | |
| Drug | zatebradine | 1.12e-06 | 17 | 28 | 3 | CID000065637 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 2.42e-06 | 3 | 27 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Ovarian cyst | 8.05e-06 | 5 | 27 | 2 | HP_0000138 | |
| Disease | Familial melanoma | 2.25e-05 | 8 | 27 | 2 | cv:C1512419 | |
| Disease | Malignant melanoma of skin | 2.25e-05 | 8 | 27 | 2 | cv:C0151779 | |
| Disease | Melanoma | 2.25e-05 | 8 | 27 | 2 | cv:C0025202 | |
| Disease | familial melanoma (is_implicated_in) | 2.89e-05 | 9 | 27 | 2 | DOID:6846 (is_implicated_in) | |
| Disease | Familial Atypical Mole Melanoma Syndrome | 4.41e-05 | 11 | 27 | 2 | C2314896 | |
| Disease | melanoma | 2.06e-04 | 126 | 27 | 3 | EFO_0000756 | |
| Disease | Pigmented Basal Cell Carcinoma | 3.00e-04 | 28 | 27 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 3.22e-04 | 29 | 27 | 2 | C4721806 | |
| Disease | melanoma (is_implicated_in) | 4.44e-04 | 34 | 27 | 2 | DOID:1909 (is_implicated_in) | |
| Disease | hepatocellular carcinoma | 6.47e-04 | 41 | 27 | 2 | EFO_0000182 | |
| Disease | liver cirrhosis (is_implicated_in) | 7.11e-04 | 43 | 27 | 2 | DOID:5082 (is_implicated_in) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 7.11e-04 | 43 | 27 | 2 | DOID:9261 (is_marker_for) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 7.79e-04 | 45 | 27 | 2 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 7.79e-04 | 45 | 27 | 2 | EFO_0004623, EFO_0004792 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.20e-03 | 56 | 27 | 2 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | serum albumin measurement | 1.95e-03 | 592 | 27 | 4 | EFO_0004535 | |
| Disease | skin neoplasm | 2.09e-03 | 74 | 27 | 2 | EFO_0004198 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRLPRILIVHLKRYS | 511 | Q9BXU7 | |
| RHLETLIRSYPDIRR | 646 | Q17RC7 | |
| LRYRHCLTTLTVPRR | 431 | Q52LR7 | |
| HIYLRSRTRLPTLLR | 616 | O60477 | |
| RYHSIVTLPRARRAV | 151 | Q01726 | |
| RYSSRRATPRHIIVR | 206 | Q9UN81 | |
| LLRDPYALRSVRHLI | 336 | P15735 | |
| LRLLRLSRLIRYIHQ | 386 | Q9Y3Q4 | |
| LYVRTTHRLLFRCPR | 276 | Q9NYR8 | |
| YLAVRHPLRSRALRT | 121 | O60755 | |
| RRRELHIRTYAVIPL | 2356 | Q13535 | |
| LRLLRLSRLIRYIHQ | 266 | O60741 | |
| RIISPYRTPVLRRHR | 1021 | Q6WRI0 | |
| SLSLPSRHRLFLTYR | 86 | Q9C0J1 | |
| LSIHRLTLERPALRY | 261 | Q8TAL5 | |
| RCLLSHYRSLEPRTL | 26 | K9M1U5 | |
| RLRPSRNFHYITILR | 311 | Q96MM7 | |
| PIQRLLHYRLLLRRL | 681 | O94887 | |
| LHIVTRIKSTRRRPY | 66 | Q8TCC3 | |
| RRLRYTLSPLLELRA | 326 | P0C7N4 | |
| LRRLRYTLSPLLELR | 326 | A6NGB0 | |
| VHRLLRKLLSRYRLP | 461 | Q9Y4C2 | |
| RLRVHLPSSIYRLLA | 566 | Q9HCE1 | |
| YLLRLRRIHRRTPRS | 581 | Q9Y227 | |
| LRHSPRLRVISRTLS | 1571 | Q7Z443 | |
| VRTAYPSLRLLHAVR | 266 | Q92186 | |
| LTPLRYDLRDRITRL | 2191 | Q9UKZ4 | |
| HLSILPSCRRYIRRL | 766 | O95155 | |
| ISRLPSALRRHYNRR | 296 | Q9Y4F4 | |
| RSLLRSHYREVLPLA | 11 | O14746 |